A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol
Clinical trial NCT01817452 · COMPLETED
Trial details
- NCT number
- NCT01817452
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2025-01-15
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.